Jakob Dupont

ATRA

Jakob Dupont serves as director at Atara Biotherapeutics, Inc. (ATRA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

13 trades

$680.1K

Net Position

Net Seller

$680.1K

Companies Traded

PYXS, ATRA

Active Period

May 2021 – Jul 2026

13 total trades

Most Recent

Sell PYXS

Jul 2, 2026 · $107.1K

Jakob Dupont's Insider Trading at Atara Biotherapeutics, Inc. (ATRA)

Buys

0 · $0.00

Sells

12 · $573.0K

Total Shares Bought

Total Shares Sold

49,169

ATRA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 2, 2023	Sell	5,074	$3.63	$18.4K
Nov 16, 2022	Sell	4,342	$4.49	$19.5K
Aug 16, 2022	Sell	4,124	$5.03	$20.8K
May 17, 2022	Sell	3,873	$5.32	$20.6K
Mar 1, 2022	Sell	2,221	$9.86	$21.9K
Feb 10, 2022	Sell	5,000	$16.00	$80.0K
Jan 3, 2022	Sell	5,000	$16.01	$80.0K
Dec 1, 2021	Sell	5,000	$17.94	$89.7K
Nov 16, 2021	Sell	2,199	$17.12	$37.6K
Nov 2, 2021	Sell	5,000	$16.41	$82.0K
Aug 17, 2021	Sell	2,152	$12.53	$27.0K
May 18, 2021	Sell	5,184	$14.55	$75.4K

Jakob Dupont's Insider Trading at Pyxis Oncology, Inc. (PYXS)

Buys

0 · $0.00

Sells

1 · $107.1K

Total Shares Bought

Total Shares Sold

35,000

PYXS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 2, 2026	Sell	35,000	$3.06	$107.1K	38,741

Related Insiders

Brian N Cherry

director

ATRABuy · Sep 4, 2026

AnhCo Nguyen

President and CEO

ATRASell · Aug 26, 2026

Yanina Grant-Huerta

officer: Chief Accounting Officer

ATRASell · May 20, 2026

EcoR1 Capital, LLC

10 percent owner

ATRABuy · May 11, 2026

Panacea Innovation Ltd

10 percent owner

ATRASell · May 11, 2026

HUMPHREY RACHEL

director

PYXSSell · Mar 25, 2026

Explore More Insider Trading Data

ATRA Insider Trading Activity

View all insider trades at Atara Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity